期刊文献+

利奈唑胺治疗儿童社区获得性金黄色葡萄球菌肺炎的临床疗效分析 被引量:8

Clinical efficacy of linezolid in the treatment of community-acquired Staphylococcus aureus pneumonia in children
下载PDF
导出
摘要 目的分析儿童社区获得性金葡菌肺炎应用利奈唑胺治疗的临床疗效。方法选择2008年1月1日—2009年3月1日在青岛大学医学院附属医院儿科及青岛市儿童医院诊断并住院治疗的社区获得性金葡菌肺炎患儿22例为研究对象,通过对住院天数、体温变化、肺部影像学改变以及实验室指标的变化进行分析,判断其临床效果。结果患儿的体温开始下降时间为(1.8±0.4)d,体温恢复正常的时间为(2.7±1.7)d,住院时间为(13.0±2.3)d,外周血白细胞(WBC)、C反应蛋白(CRP)和红细胞沉降率(ESR)恢复正常的时间分别为(8.29±2.81)d、(13.29±2.77)d和(13.14±3.72)d,总有效率100%,不良反应发生率4.6%。结论利奈唑胺治疗儿童社区获得性金葡菌肺炎效果可靠。 Objective To evaluate the clinical efficacy of linezolid in the treatment of community-acquired Staphylococcus aureus (CA-SA) pneumonia in children.Methods Twenty-two cases of CA-SA pneumonia in children were diagnosed in Department of Pediatrics,Affiliated Hospital of Qingdao University Medical School,and Qingdao Children′s Hospital from January 1,2008 to March 1,2009.Clinical data such as hospital stay,body temperature,radiology,microbiology and peripheral white blood cell (WBC),C-reactive protein (CRP),erythrocyte sedimentation rate (ESR) indices were evaluated.Results The average hospital stay was 13.0± 2.26 days.Body temperature returned to normal within 2.7 ± 1.7 days.WBC,CRP,ESR resumed normal within 8.29±2.81,13.29±2.77,and 13.14±3.72 days,respectively.The overall response rate was 100%.The incidence of adverse reactions was 4.6%.Conclusions Linezolid shows reliable efficacy in the treatment of CA-SA pneumonia in children.
出处 《中国感染与化疗杂志》 CAS 2010年第4期258-260,共3页 Chinese Journal of Infection and Chemotherapy
关键词 金黄色葡萄球菌 利奈唑胺 社区获得性肺炎 儿童 Staphylococcus aureus linezolid community-acquired pneumonia children
  • 相关文献

参考文献4

二级参考文献59

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:784
  • 3DIEKENA DI, JONES RN. Oxazolidinones: a review [ J ]. Drugs, 2000,59( 1 ) :7 - 16.
  • 4MOELLERING RC JR. Linezolid:the first oxazolidinone antimicrobial[ J], Ann Intern Med,2003,138(2) :135 - 142.
  • 5MEAGHER AK, FORREST A, RAYNER CA, et al. Population pharmacoklnetics of linezalid in patients treated in a compassionate-use program [ J ]. Antimicrob Agents Chemother, 2003,47 ( 2 ) : 548 - 553.
  • 6JANKOWSKI A, STEFANI KW. Linezolid-novel antibiotic for the treatment of gram-positive bacterial infections [ J ]. Wiad Lek, 2006,59(9/10) :727 -731.
  • 7RICHARD G, WUNDERINK MD, JORDI RELLO,et al. Linezolid vs Vancomycin. Analysis of two double-blinded studies of patients with methicillin-resistant staphylococcus aureus nosocomial pneumonia[ J ]. Chest,2003,124 ( 5 ) : 1789 - 1797.
  • 8ZEANA C, KUBIN C J, LA-LATTA P,et al. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid :case report and review of the literature[ J]. Clin Infect Dis, 2001,33 ( 15 ) :477 - 482.
  • 9AMENT PW, JAMSHED N, HOME JP. Linezolid : its role in the treatment of gram-positive,drug-resistant bacterial infections[ J ]. Am Fam Physician ,2002,65 (4) :663 - 670,
  • 10HAMEL JC, STAPERT D, MOERMAN JK, et al. Linezolid, critical characterstics[ J]. Infection,2000,28 ( 1 ) :60 - 64.

共引文献3928

同被引文献95

  • 1熊伟坚.经皮肺脓肿穿刺抽吸术的临床应用[J].现代医院,2004,4(9):73-74. 被引量:4
  • 2邢志广,孙文萱,周位强,王志勤,姜锋,苏莉.葡萄球菌属的分离鉴定与耐药性监测[J].中华医院感染学杂志,2007,17(7):881-884. 被引量:31
  • 3胡亚美,江载哥,主编.实用儿科学[M].7版.北京:人民卫生出版社,2008:1171-1181.
  • 4朱德妹.2005年中国CHINET葡萄球菌属耐药性分析[J].中国感染与化疗杂志,2007,7(4):269-273. 被引量:72
  • 5叶应妩,王毓三.全国临床检验操作规程第三版[M].南京:东南大学出版社,1999:379-398.
  • 6Leach KL, Briekner S J, Noe MC, et al. Linezolid, the first oxazolidinone antibacterial agent. Ann N Y Acad Sci, 2011, 1222:49-54.
  • 7Kearns GL, Abdel-Rahman SM, Blumer JL, et al. Single dose pharmacokinetics of linezolid in infants and children. Pediatr Infect Dis J, 2000,19 : 1178-1184.
  • 8ZYVOX (linezolid) FDA Prescribing Information ( 2012-02-13 ) [ 2012-07-20 ]. http ://www. aceessdata, fda. gov/.
  • 9Kaplan SL, Patterson L, Edwards KM, et al. Linezolid for the treatment of community-acquired pneumonia in hospitalized children. Linezolid Pediatric Pneumonia Study Group. Pediatr Infect Dis J, 2001, 20:488-494.
  • 10Kaplan SL, Deville JG, Yogev R, et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J, 2003,22:677-686.

引证文献8

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部